Posaconazole Tablet, Delayed Release
Product Images NDC 0904-7149

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 0904-7149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Posaconazole (32b94024 0ca5 4767 9c72 B1f8ec8699ae 01)

Chemical structure diagram of posaconazole, the active ingredient in POSACONAZOLE 100 mg delayed-release tablets by Major Pharmaceuticals. The structure shows the arrangement of multiple aromatic rings, fluorine atoms, and heterocyclic components characteristic of posaconazole.*

FDA Label Image

A31d5f4a A9f2 45a7 A590 855086b52638 00

POSACONAZOLE 100 mg delayed-release tablets label from Major Pharmaceuticals. The image shows a unit dose package containing 30 tablets, with the product proprietary name, strength, dosage form, route of administration as oral, and the NDC number 0904-7149-04. Additional information includes prescription status, manufacturer details, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.